At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 7 enrolled
Drug / intervention
Theophyllinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Helping Olfaction and Nutrition On Renal Replacement
In Brief
A Phase 2 clinical trial evaluating Theophylline for End Stage Renal Disease and Olfactory Disorders. Completed, enrolled 7 participants across 1 site.
Detailed Summary
This clinical trial examines whether nasal theophylline administration can improve olfaction and nutrition in hemodialysis patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEnd Stage Renal Disease, Olfactory Disorders
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 2015
Enrollment StartOct 2015
Primary CompletionJul 2022
TodayJul 2026
First PostedJun 24, 2015
Enrollment StartOct 1, 2015
Primary CompletionJul 1, 2022
TodayJul 2, 2026
Enrollment to primary: 6.8 yearsPosted 11.0 years ago
Interventions
Theophyllinedrug
The study medication will be provided by Foundation Care.